Matthew Rizzo - Profile and Investment Details

Investor Profile

Matthew Rizzo is a Venture Capital, Private Equity Firm, Investor based in Clinton, New Jersey, United States with a diverse investment portfolio that includes companies such as Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics, Olema Oncology, Aerin Medical, CoreMapNewMed Medical, BioShin, Scribe Therapeutics, X4 Pharmaceuticals, Visen Pharmaceuticals, Abbisko Therapeutics, Sonendo, Cullinan Oncology, Silverback Therapeutics, Harbour Biomed, Nuvation Bio, Century Therapeutics, GentiBio, Decibel Therapeutics, Cytek Biosciences, Caris Life Sciences, UNUM Therapeutics, Scorpion Therapeutics, Crossover Health, PMV Pharmaceuticals, Immvira, Verona Pharma, Adagio Therapeutics, Zhaoke Ophthalmology Pharmaceutical, Pandion Therapeutics, Adimab, Cleave Therapeutics, Adicet Bio, BlossomHill Therapeutics, Ikena Oncology, AbCellera Biologics, Nucleix, Aspen Neuroscience, VectivBio, GrayBug, ReViral, Harmony Biosciences, Graphite Bio, RayzeBio, Erasca, MobileODT, Terns Pharmaceuticals, Repare Therapeutics, AnchorDx, Ventyx Biosciences, Clover Biopharmaceuticals, Protekt Therapeutics, Nuohui Health, I-Mab Biopharma, InventisBio, Prelude Therapeutics, Gracell Biotechnologies, Ruipeng Pet Healthcare, Janux Therapeutics, ImmPACT Bio USA, ORIC Pharmaceuticals, MBX Biosciences, Enliven Therapeutics, Acutus Medical, Foamix, Miaoshou Doctor, Delfi Diagnostics, Rongchang Pharmaceutical, Remegen, Noctrix Health, MabPlex International, Passage Bio, Chinook Therapeutics, Keros Therapeutics, Alizé Pharma, Chemomab, MDClone, Fore Biotherapeutics, VelosBio, Achilles Therapeutics, Galecto, NeuroPace, Kinnate Biopharma, Q32 Bio, Azura Ophthalmics, ReCode Therapeutics, TytoCare, ESCAPE Bio, Arcutis Biotherapeutics, . Over time, Matthew Rizzo has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Matthew Rizzo is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Drug Discovery, Wellness, Rare Diseases, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Information Technology (IT), Venture Fundraising, Mobile, Finance, Biotechnology, Healthcare IT, Medical Devices, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Precision Medicine, Innovation, Clinical Trials, Research, Gene Therapy, Medical Diagnostics, Health Diagnostics, Digital Health, Travel, Medical, Information Technology, B2B, Therapeutics, Health Tech, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Matthew Rizzo, as their portfolio suggests a familiarity and interest in this area.

Understanding Matthew Rizzo’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.